Table 4.
Final dose of ketoconazole used in patients with Cushing’s disease.
| Final dose | Controlled/partially controlled | Uncontrolled |
|---|---|---|
| ≤100 mg | 1 (4%) | 0 |
| 200 mg | 2 (8%) | 0 |
| 300 mg | 0 | 1 (12.5%) |
| 400 mg | 6 (24%) | 2 (25%) |
| 600 mg | 9 (36%) | 3 (37.5%) |
| 800 mg | 6 (24%) | 2 (25%) |
| 1,000 mg | 1 (4%) | 0 |